Virco Manufacturing Corporation’s VIRC shares tumbled 2.6% during Monday’s trading hours after it reported an adjusted loss in the fourth quarter of fiscal 2024 (ended Jan. 31, 2025), with the ...

Virco Manufacturing Corporation VIRC reported mixed second-quarter fiscal 2024 (ended July 31, 2024) results, wherein earnings surpassed the Zacks Consensus Estimate but sales missed the same.

Company Background Virco is a multinational biotechnology company with operating subsidiaries in the United States, Belgium, The United Kingdom and Ireland. It applies the most advanced ...

Virco will market SmartGene ... to facilitate sequence-based analysis for a variety of clinical, medical research, and veterinary applications. Constant updates to reference data and interpretive ...